期刊文献+

Ang-(1-7)通过G蛋白偶联受体Mas在人肝癌细胞HepG2中的作用 被引量:1

The Effect of Ang-(1-7) on Human Hepatocellular Carcinoma Cells: HepG2 by G Protein Coupled Receptor Mas
原文传递
导出
摘要 为了研究Ang-(1-7)通过Mas对人肝癌细胞增殖的影响及在Mas高、低表达模型中分析其表达差异、凋亡等细胞生理活性变化,我们采用药物(Mas激活剂Ang-(1-7),Mas抑制剂A779)干预Hep G2细胞,分别对Ang-(1-7)和A799进行剂量、时间效应实验,实时定量RT-PCR检测药物干预后细胞Mas的表达水平,最后流式细胞仪检测药物干预后细胞的凋亡变化。结果表明,Ang-(1-7)与A779的有效工作浓度为10-7mol/L,Ang-(1-7)促进Mas的表达,Mas表达水平高于对照组。相反,A779抑制Mas的表达,但作用不明显,主要为拮抗Ang-(1-7)的功能。Ang-(1-7)处理组细胞凋亡明显升高,揭示Mas表达提升诱导人肝癌细胞凋亡。 To investigate the effect of Ang-(1-7) on the proliferation of human primary hepatocellular carcinoma(HCC) cells by Mas and analyze the expression differences in physiological activity and cell apoptosisthe in Mas(high and low) model, we applied drugs intervention on Hep G2 cells. Determining the effective concentration by the experiment of dose effect and dose dependence experiment, apply Real-time quantitative RT-PCR to detect the expression level of mas after drug intervention and detect the changes of cell apoptosis by flow cytometry instrument. As the results, the effective concentration of Ang-(1-7) and A779 were both 10-7mol/L. Ang-(1-7) can promote the expression of mas, in the RT-PCR the expression level of mas was higher than the control which was opposite of A779. Up-reguluted mas promoted the apoptosis of human hepatocarcinoma cells obviously.
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2015年第6期1149-1154,共6页 Genomics and Applied Biology
基金 国家自然科学基金(81160263) 广西教育厅科研项目(200103YB025)共同资助
关键词 MAS HEPG2细胞 药物干预 激活剂 抑制剂 细胞凋亡 Mas,HepG2 cell,Drugs intervention,Activator,Inhibitor,Cell apoptosis
  • 相关文献

参考文献1

二级参考文献11

  • 1Ariake K., Ohtsuka H., Motoi F., Douchi D., Oikawa M., Rikiya- ma T., Fukase K., Katayose Y., Egawa S., and Unno M., 2012, GCF2/LRRFIP1 promotes colorectal cancer metasta- sis and liver invasion through integrin-dependent RhoA acti- vation, Cancer Lett., 325(1): 99-107.
  • 2Boucher E., Fomer A., Reig M., and Bruix J., 2009, New drugsfor t he treatment of hepatocellular carcinoma, Liver Int., (S1): 148-158.
  • 3Li J.P., Cao N.X., Jiang R.T., He S.J., Huang T.M., Wu B., Chen D. F., Ma P., Chen L., Zhou S.F., Xie X.X., and Luo G.R., 2014, Knockdown of GCF2/LRRFIP1 by RNAi causes cell growth inhibition and increased apoptosis in human hepatoma HepG2 cells, Asian Pac. J. Cancer Prev., 15(6): 2753-2758.
  • 4Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., and Karin M., 2007, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL6 production, Science, 317(5834): 121-124.
  • 5Ohtsuka H., Oikawa M., Ariake K., Rikiyama T., Motoi F., Katayose Y., Unno M., and Johnson A.C., 2011, GCF2 inter- acts with dishevelled and regulates Wnt signaling pathways inhuman carcinoma cell lines, Int. J. Cancer, 129(7): 1599-1610.
  • 6Rikiyama T., Curtis J., Oikawa M., Zimonjic D.B., Popescu N., Murphy B.A., Wilson M.A., and Johnson A.C., 2003, GCF2: expression and molecular analysis of repression, Biochim. Biophys. Acta, 1629(1-3): 15-25.
  • 7Shimizu Y., Hishiki T., Ujino S., Sugiyama K., Funami K., and Shimotohno K., 2011, Lipoprotein component associated with hepatitis C virus is essential for virus infectivity, Curr. Opin. Virol., 1(1): 19-26.
  • 8Suriano A.R., Sanford A.N., Kim N., Oh M., Kennedy S., Hen- derson M.J., Dietzmann K., and Sullivan K.E., 2005, GCF2/LRRFIP1 represses tumor necrosis factor alpha ex- pression, Mol. Cell Biol., 25(20): 9073-9081.
  • 9Wang J.Q., Jeelall Y.S., Ferguson L.L., and Horikawa K., 2014, Toll-like receptors and cancer: MYD88 mutation and in- flammation, Front. Immunol., 31(5): 367.
  • 10Wu J., Li J., Salcedo R., Mivechi N.F., Trinchieri G., and Ho- ruzsko A., 2012, The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development o f hepatocellular carcinoma, Cancer Res., 72(16): 3977 -3986.

共引文献3

同被引文献16

  • 1席翼,张秀丽,胡扬,刘刚,张海霞,包大鹏,吴剑.中国优秀马拉松运动员ACE基因I/D多态性频率分布特征[J].中国运动医学杂志,2006,25(4):391-394. 被引量:13
  • 2高炳宏,陈佩杰,董强刚,杨震.上海地区汉族优秀游泳运动员ACE基因I/D多态性研究[J].中国运动医学杂志,2006,25(5):517-521. 被引量:11
  • 3Pereira A,Costa A.M,Leit觔o J.C,Monteiro A.M,Izquierdo M,Silva A.J,Bastos E,Marques M.C.The influ ence of ACE ID and ACTN3 R577X polymorphisms on lower-extremity function in older women in response to high-speed power training. BMC Geriatrics . 2013
  • 4Woods David.Angiotensin-converting enzyme, renin-angiotensin system and human performance. Medicine and sport science . 2009
  • 5Montgomery H E,Marshall R,Hemingway H,Myerson S,Clarkson P,Dollery C,Hayward M,Holliman D E,J ubb M,World M,Thomas E L,Brynes A E,Saeed N,Barnard M,BellJ D,Prasad K,Rayson M,Talmud P J,Humphries S E.Human gene for physical performance. Nature . 1998
  • 6Zudin Puthucheary,James Skipworth,Jai Rawal,Mike Loosemore,Ken Van Someren,Hugh Montgomery.The ACE Gene and Human Performance: 12 Years On. Sports Medicine . 2011
  • 7Myerson S,Hemingway H,Budget R,et al.Human angiotensin I-converting enzyme gene and endurance performance. Journal of Applied Physiology . 1999
  • 8George Gayagay,Bing Yu,Brett Hambly,Tanya Boston,Alan Hahn,David S. Celermajer,R. J. Trent.??Elite endurance athletes and the ACE I allele – the role of genes in athletic performance(J)Human Genetics . 1998 (1)
  • 9叶新钢,李泽龙,刘家玉.ACE基因多态性与运动耐力的相关性分析[J].青岛大学医学院学报,2010,46(6):482-484. 被引量:3
  • 10潘力平,郑陆,姚维国,高丽,张晓东,苗向军.我国优秀篮球运动员ACE基因I/D多态性频率分布特征研究[J].山东体育学院学报,2011,27(12):46-49. 被引量:6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部